These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 6288184)

  • 21. Overeating after midbrain 6-hydroxydopamine: prevention by central injection of selective catecholamine reuptake blockers.
    Hernandez L; Hoebel BG
    Brain Res; 1982 Aug; 245(2):333-43. PubMed ID: 6812851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment.
    Archer T; Palomo T; McArthur R; Fredriksson A
    Neurotox Res; 2003; 5(1-2):95-110. PubMed ID: 12832225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperactivity following intradentate injection of colchicine: a role for dopamine systems in the nucleus accumbens.
    Emerich DF; Walsh TJ
    Pharmacol Biochem Behav; 1990 Sep; 37(1):149-54. PubMed ID: 2124711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesolimbic dopamine and early post-6-OHDA lesion enhanced responses to d-amphetamine.
    Lynch MR; Carey RJ
    Pharmacol Biochem Behav; 1989 Feb; 32(2):577-80. PubMed ID: 2498910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased sensitivity to amphetamine and facilitation of amphetamine self-administration after 6-hydroxydopamine lesions of the amygdala.
    Deminière JM; Taghzouti K; Tassin JP; Le Moal M; Simon H
    Psychopharmacology (Berl); 1988; 94(2):232-6. PubMed ID: 3127850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
    Spyraki C; Fibiger HC
    Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphetamine reverses learning deficits in 6-hydroxydopamine-treated rat pups.
    Wool RS; Weldon DA; Shaywitz BA; Anderson GM; Cohen DJ; Teicher MH
    Dev Psychobiol; 1987 Mar; 20(2):219-32. PubMed ID: 3108057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi.
    Kelly PH; Roberts DC
    Pharmacol Biochem Behav; 1983 Jul; 19(1):137-43. PubMed ID: 6413984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of hyperactivity in adult rats induced by neonatal intraventricular 6-hydroxydopamine following pargyline or desmethylimipramine treatment.
    Olds ME; Yuwiler A
    Psychopharmacology (Berl); 1985; 87(4):484-9. PubMed ID: 3936107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.
    Davids E; Zhang K; Tarazi FI; Baldessarini RJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):92-8. PubMed ID: 11862378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine.
    Avale ME; Nemirovsky SI; Raisman-Vozari R; Rubinstein M
    J Neurosci Res; 2004 Oct; 78(2):289-96. PubMed ID: 15378510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of methamphetamine on the locomotor activity in the 6-OHDA dorsal hippocampus lesioned rat.
    Itoh K; Fukumori R; Suzuki Y
    Life Sci; 1984 Feb; 34(9):827-33. PubMed ID: 6422178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.
    Winstanley CA; Theobald DE; Dalley JW; Robbins TW
    Neuropsychopharmacology; 2005 Apr; 30(4):669-82. PubMed ID: 15688093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats.
    Fink JS; Smith GP
    Brain Res; 1980 Oct; 199(2):359-84. PubMed ID: 7417789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diminished amphetamine anorexia and enhanced fenfluramine anorexia after midbrain 6-hydroxydopamine.
    Ahlskog JE; Randall PK; Hernandez L; Hoebel BG
    Psychopharmacology (Berl); 1984; 82(1-2):118-21. PubMed ID: 6420820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
    Gold LH; Swerdlow NR; Koob GF
    Behav Neurosci; 1988 Aug; 102(4):544-52. PubMed ID: 3139012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.